This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for November 5 to approve September results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.8 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 5, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026, along with a limited review report from the statutory auditor. No financial figures are provided. Trading has been closed since October 1 and will reopen 48 hours after the results are declared.
The filing sets a date for financial updates but provides no results or outlook, so the impact on earnings or the stock cannot yet be assessed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.13 Cr | ₹0.07 Cr | +76.1% |
| Operating profit | ₹0.01 Cr | ₹0.01 Cr | +64.6% |
| Profit after tax | ₹0.01 Cr | ₹0.01 Cr | +59.7% |
| EBITDA margin | 39.4% | 63.0% | −23.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.